Breaking News
Get 40% Off 0
⚠ Earnings Alert! Which stocks are poised to surge?
See the stocks on our ProPicks radar. These strategies gained 19.7% year-to-date.
Unlock full list
Close

Sino Biopharmaceutical Ltd (1177)

Create Alert
New!
Create Alert
Website
  • As an alert notification
  • To use this feature, make sure you are signed-in to your account
Mobile App
  • To use this feature, make sure you are signed-in to your account
  • Make sure you are signed-in with the same user profile

Condition

Frequency

Once
%

Frequency

Frequency

Delivery Method

Status

Add to/Remove from Watchlist Add to Watchlist
Add to Watchlist
Add Position

Position added successfully to:

Please name your holdings portfolio
 
2.34 -0.09    -3.70%
04:08:33 - Closed. Currency in HKD ( Disclaimer )
Type:  Equity
Market:  Hong Kong
ISIN:  KYG8167W1380 
  • Volume: 133,647,456
  • Bid/Ask: 2.33 / 2.34
  • Day's Range: 2.29 - 2.43
Sino Biopharmaceutical 2.34 -0.09 -3.70%

1177 Ratios

 
Assess the performance of Sino Biopharmaceutical (1177). This table contains core financial ratios such as Price-to-Earnings (P/E ratio), Return-On-Investment (ROI), Earnings per share (EPS), Dividend yield and others based on Sino Biopharmaceutical Ltd's latest financial reports. Compare the performance metrics of Sino Biopharmaceutical (1177) against the industry averages.
InvestingPro Advanced Ratios
Name Company Industry
   
P/E Ratio TTM 21.48 0.16
Price to Sales TTM 1.51 3.47
Price to Cash Flow MRQ - 4.23
Price to Free Cash Flow TTM - -0.79
Price to Book MRQ 1.3 0.93
Price to Tangible Book MRQ 1.49 1.1
   
Profitability: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Gross margin TTM 80.95% 67.65
Gross Margin 5YA 79.5% 22.11
Operating margin TTM 20.76% -39.85
Operating margin 5YA 18.89% -1,807.27
Pretax margin TTM 20.65% -25.51
Pretax margin 5YA 36.05% -4,342.73
Net Profit margin TTM 8.9% -25.7
Net Profit margin 5YA 32.19% -4,343.77
   
Revenue/Share TTM 1.42 10.93
Basic EPS ANN 0.13 7.14
Diluted EPS ANN 0.13 7.1
Book Value/Share MRQ 1.66 4.77
Tangible Book Value/Share MRQ 1.5 -41.7
Cash/Share MRQ 0.51 2.22
Cash Flow/Share TTM - 0.48
   
Management Effectiveness: TTM vs 5 Year Average Margins
 TTM (%)
 5 Year Avg. (%)
Return on Equity TTM 6.13% 2.69
Return on Equity 5YA 22.38% 1.04
Return on Assets TTM 7.99% 1.61
Return on Assets 5YA 14.36% 1.32
Return on Investment TTM 9.1% 1.61
Return on Investment 5YA 9.42% 2.25
   
EPS(MRQ) vs Qtr. 1 Yr. Ago MRQ 0% 6.44
EPS(TTM) vs TTM 1 Yr. Ago TTM -7.86% 2.83
5 Year EPS Growth 5YA -23.73% 5.67
Sales (MRQ) vs Qtr. 1 Yr. Ago MRQ 0% 23.67
Sales (TTM) vs TTM 1 Yr. Ago TTM -8.97% 12.01
5 Year Sales Growth 5YA 4.63% 15.77
5 Year Capital Spending Growth 5YA 0% 8.23
   
Quick Ratio MRQ 0.76 1
Current Ratio MRQ 1.05 2.08
LT Debt to Equity MRQ 3.53% 5.1
Total Debt to Equity MRQ 41.28% 18.54
Efficiency    
Asset Turnover TTM 0.41 0.43
Inventory Turnover TTM 2.31 2.16
Revenue/Employee TTM 1.02M 822.89K
Net Income/Employee TTM 197.53K 35.84K
Receivable Turnover TTM - 4.81
   
Dividend Yield ANN 2.31% 1.03
Dividend Yield 5 Year Avg. 5YA 2.58% 0.8
Dividend Growth Rate ANN -77.27% 7.91
Payout Ratio TTM - 50.55
TTM = Trailing Twelve Months  5YA = 5-Year Average  MRQ = Most Recent Quarter
InvestingPro
Go to Dashboard InvestingPro

Unlock access to over 1000 metrics with InvestingPro

View advanced valuation and financial ratios for in-depth analysis of company financial performance.

 
Comment Guidelines

We encourage you to use comments to engage with other users, share your perspective and ask questions of authors and each other. However, in order to maintain the high level of discourse we’ve all come to value and expect, please keep the following criteria in mind:  

  •            Enrich the conversation, don’t trash it.

  •           Stay focused and on track. Only post material that’s relevant to the topic being discussed. 

  •           Be respectful. Even negative opinions can be framed positively and diplomatically. Avoid profanity, slander or personal attacks directed at an author or another user. Racism, sexism and other forms of discrimination will not be tolerated.

  • Use standard writing style. Include punctuation and upper and lower cases. Comments that are written in all caps and contain excessive use of symbols will be removed.
  • NOTE: Spam and/or promotional messages and comments containing links will be removed. Phone numbers, email addresses, links to personal or business websites, Skype/Telegram/WhatsApp etc. addresses (including links to groups) will also be removed; self-promotional material or business-related solicitations or PR (ie, contact me for signals/advice etc.), and/or any other comment that contains personal contact specifcs or advertising will be removed as well. In addition, any of the above-mentioned violations may result in suspension of your account.
  • Doxxing. We do not allow any sharing of private or personal contact or other information about any individual or organization. This will result in immediate suspension of the commentor and his or her account.
  • Don’t monopolize the conversation. We appreciate passion and conviction, but we also strongly believe in giving everyone a chance to air their point of view. Therefore, in addition to civil interaction, we expect commenters to offer their opinions succinctly and thoughtfully, but not so repeatedly that others are annoyed or offended. If we receive complaints about individuals who take over a thread or forum, we reserve the right to ban them from the site, without recourse.
  • Only English comments will be allowed.
  • Any comment you publish, together with your investing.com profile, will be public on investing.com and may be indexed and available through third party search engines, such as Google.

Perpetrators of spam or abuse will be deleted from the site and prohibited from future registration at Investing.com’s discretion.

1177 Comments

Write your thoughts about Sino Biopharmaceutical Ltd
 
Are you sure you want to delete this chart?
 
Post
Post also to:
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Thanks for your comment. Please note that all comments are pending until approved by our moderators. It may therefore take some time before it appears on our website.
JAME Megueni
VRAQ Jun 29, 2022 10:28PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
HSBC Global Research: SINO BIOPHARM Acquisition of F-Star Should Improve Pipeline, Rating Buy
JAME Megueni
VRAQ Feb 15, 2022 9:03PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
HSBC Global Research Cuts SINO BIOPHARM TP to $9, Rated Buy
JAME Megueni
VRAQ Jan 20, 2022 8:46PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
UBS Adds SINO BIOPHARM TP to $11.6, Rated Buy
JAME Megueni
VRAQ Sep 02, 2021 11:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
M Stanley Trims CHINA CINDA TP to $1.63; Rated Equalweight
JAME Megueni
VRAQ Sep 02, 2021 11:39PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Daiwa Axes SINO BIOPHARM TP to $11; Rated Buy
JAME Megueni
VRAQ Aug 18, 2021 11:07PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
SINO BIOPHARM Shr Once Rebounds Over 9% as Interim NP May Hike Over 5x
JAME Megueni
VRAQ Jul 27, 2021 10:57PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
SINO BIOPHARM Repurchases $28.53M Shrs; Tse Ping, Tse Hsin Splurge Over $100M to Add Stakes
Jarvis Wang
Jarvis Wang Jun 01, 2021 9:35PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
WHO agree SinoVac into EUA list at Jun 01, that Sino Biopharm have 15.3%
JAME Megueni
VRAQ May 24, 2021 10:53PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
Macquarie Upgrades SINO BIOPHARM to *Outperform* with $10.46 TP
JAME Megueni
VRAQ Mar 15, 2021 10:16PM ET
Saved. See Saved Items.
This comment has already been saved in your Saved Items
JPM Raises SINO BIOPHARM TP to $13.5; Rated ***Overweight***
 
Are you sure you want to delete this chart?
 
Post
 
Replace the attached chart with a new chart ?
1000
Your ability to comment is currently suspended due to negative user reports. Your status will be reviewed by our moderators.
Please wait a minute before you try to comment again.
Add Chart to Comment
Confirm Block

Are you sure you want to block %USER_NAME%?

By doing so, you and %USER_NAME% will not be able to see any of each other's Investing.com's posts.

%USER_NAME% was successfully added to your Block List

Since you’ve just unblocked this person, you must wait 48 hours before renewing the block.

Report this comment

I feel that this comment is:

Comment flagged

Thank You!

Your report has been sent to our moderators for review
Continue with Google
or
Sign up with Email